As of November 2024, Virax Biolabs Group has a market cap of $4.87M. This makes Virax Biolabs Group the world's 34587th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.48M | -44.11% |
2023 | $2.64M | -80.00% |
2022 | $13.22M | - |